Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aifred Health has completed a large North American clinical trial demonstrating that its AI-powered clinical decision support device improves the personalization and effectiveness of treatment selection for moderate to severe depression. The device received Canadian regulatory approval in September 2024 and demonstrated significant benefits over standard care by reducing time to remission and improving patient outcomes. US regulatory filings are underway.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aifred Health.